Global, regional, and national burden of early-onset and late-onset colorectal cancer attributable to high body-mass index from 1990 to 2021: a trend analysis and forecasts up to 2040 based on the global burden of disease study 2021

Hepatology

Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia-Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021

J Gastroenterol Hepatol

Giri S, Ingawale S, Khatana G, Gore P, Praharaj DL, Wong VW, Huang DQ, Singhal A, Choudhury A

doi: 10.1111/jgh.16922

Gastrointestinal Cancer

Clinical and demographic analysis of patients with colorectal cancer screened at a reference hospital in Southern Brazil: comparative study based on age (Retrospective cohort study)

BMC Gastroenterol

Al-Alam OCM, Alves RJV, Fae AL, Cardoso CN, Lava JR, Castro JP, Signori J, Claudino LG, Wandscheer TBC, Villarinho VV, Yao APMS, Bica CG

doi: 10.1186/s12876-025-03607-6

Inflammatory Bowel Disease

Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease

Inflamm Bowel Dis

Fumery M, Savoye G, Sarter H, Dupont-Lucas C, Bertrand V, Wils P, Richard N, Guillon N, Gower-Rousseau C, Turck D, Ley D, Leroyer A, EPIMAD group

doi: 10.1093/ibd/izaf133

Hepatology

High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: a Meta-Analysis

Clin Gastroenterol Hepatol

Kit Ho GJ, Ning Tan FX, Sasikumar NA, Jun Tham EK, Ko D, Kim DH, Danpanichkul P, Yu Z, Xianda C, Zhang ZX, Wijarnpreecha K, Pramotedham T, Noureddin M, Huang DQ, Sumida Y, Nakajima A, Zheng MH, Takahashi H, Ng CH, Muthiah M

doi: 10.1016/j.cgh.2025.02.006

ColonoscopyGastrointestinal Cancer

An organized fecal immunochemical test-based screening program impacts colorectal cancer early diagnosis and survival in the short term

Am J Gastroenterol

Silva JC, Leite-Silva P, Tavares F, Bento MJ, Libânio D, Dinis-Ribeiro M

doi: 10.14309/ajg.0000000000003797

Inflammatory Bowel Disease

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study

Lancet Gastroenterol Hepatol

D'Haens GR, Löwenberg M, Baert F, Bossuyt P, Molnár T, Hoentjen F, Clasquin E, Gecse KB, Hulshoff MS, De Hertogh G, Lenfant M, Oldenburg L, Vermeire S

doi: 10.1016/S2468-1253(25)00233-X

Gallbladder and Biliary DiseasesGastrointestinal Cancer

Gallbladder cancer and dysplasia in cholecystectomy specimens: A large study in high-incidence regions of South America

Clin Gastroenterol Hepatol

Boekstegers F, Ponce CB, Morales E, Muñoz-Castro C, Lindner C, Lira IS, Manques B, Flores AC, Valenzuela C, Castillo J, de Toro G, Almau M, Inklemona C, Ituarte C, Arroyo GF, Spencer L, Losada H, Araya JC, Nervi B, Quintanilla CM, Montenegro P, Garcia AL, Orellana SR, Ortega A, Rothhammer F, Bermejo JL

doi: 10.1016/j.cgh.2024.12.027

ColonoscopyGastrointestinal Cancer

Association Between Adenoma Detection Rate and Prevalent Colorectal Cancer Detection Rate in a National Colonoscopy Registry Subtitle: Association Between Adenoma and Colorectal Cancer Detection

Gastroenterology

Dominitz JA, Ladabaum U, Holub JL, Issaka RB, Ko CW, Robertson DJ

doi: 10.1053/j.gastro.2025.06.009

Gastrointestinal Cancer

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Eur J Cancer

Weiss L, Stintzing S, Modest DP, Stahler A, von Weikersthal LF, Reinacher-Schick A, Decker T, Probst V, Heinrich K, Schwaner I, Kaiser F, Pihusch R, Fuchs M, Held S, Alig A, Gruenberger B, Prager GW, Tougeron D, Taieb J, Heinemann V

doi: 10.1016/j.ejca.2025.116105

Related content